↓ Skip to main content

CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses

Overview of attention for article published in Science Advances, April 2025

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users
patent
1 patent
bluesky
4 Bluesky users

Readers on

mendeley
8 Mendeley